greeksoup/ stock research

Design Therapeutics, Inc. 13F holders

136 funds reported a position in Design Therapeutics, Inc. in their 13F for the quarter ended 30 June 2026, together 43.3 million shares worth $626.5 million. Against the quarter before, 26 opened a position, 61 added, 32 trimmed and 16 sold out; together they bought a net 5.3 million shares. The largest holders: SR One Capital Management, LP, Logos Global Management LP and Baker Bros. Advisors LP.

Funds holding136+11 on Q1 2026
Shares they held43.3Mworth $626.5 million
Net bought on the quarter5.3M sharesabout $76.9 million at the funds' values
Funds buying to selling87 to 48opened or added, to cut or sold
Opened 26Added 61Held 16Trimmed 32Sold out 16
Opened: 26 fundsAdded: 61 fundsHeld: 16 fundsTrimmed: 32 fundsSold out: 16 funds

What each fund did in DSGN against its 13F for the quarter before; a change under 0.1% of a holding counts as held

Q3 2024: 100 funds, 32.1 million shares100Q3 2024Q4 2024: 95 funds, 33.5 million shares95Q4 2024Q1 2025: 98 funds, 34.5 million shares98Q1 2025Q2 2025: 92 funds, 34.5 million shares92Q2 2025Q3 2025: 95 funds, 36.0 million shares95Q3 2025Q4 2025: 117 funds, 38.1 million shares117Q4 2025Q1 2026: 125 funds, 38.0 million shares125Q1 2026Q2 2026: 136 funds, 43.3 million shares136Q2 2026

Funds reporting a position in DSGN in their 13F, each quarter; hover a bar for the shares they held

Filed so far for the quarter to 30 September 2026

3,241 funds have filed their 13F for the quarter so far; the rest are due by 16 November 2026. Of those, 22 reported a position in Design Therapeutics, Inc.: 2 opened one, 10 added, 4 trimmed and 2 sold out, a net 48,136 shares bought.

The largest moves in the name among the funds that have filed, against each fund's previous 13F.

The well-known funds

Of the 44 funds followed here, 7 reported a position in Design Therapeutics, Inc. in a 13F for the quarter ended 30 June 2026. The largest: Point72 Asset Management, 2.4 million shares worth $34.2 million, 0.1% of its reported book. In the quarter, 3 funds added or opened a position and 4 trimmed or sold out; together they sold a net 226,769 shares, about $3.3 million at the funds' own value per share on 30 June 2026. A change under 0.1% of a holding counts as held.

FundSharesValueOf its bookChange on the quarterStatusQuarter endedFiling
Point72 Asset Management2,366,453$34.2 million0.1%-356,301trimmed30 June 202613F
Geode Capital Management958,417$13.9 million0.0%+265,899added30 June 202613F
FMR LLC776,462$11.2 million0.0%-21,949trimmed30 June 202613F
Renaissance Technologies387,913$5.6 million0.0%-20,287trimmed30 June 202613F
Millennium Management147,714$2.1 million0.0%+38,786added30 June 202613F
Citadel Advisors81,971$1.2 million0.0%-149,542trimmed30 June 202613F
Two Sigma Investments32,925$476,4250.0%+16,625added30 June 202613F
Value is what the fund reported.
Read moreChange is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.

The largest holders

FundSharesShare of allValueOf its bookChange in sharesFiling
SR One Capital Management, LP6,526,47615.07%$94.4 million9.09%no change13F
Logos Global Management LP3,000,0006.93%$43.4 million1.87%+1,050,00013F
Baker Bros. Advisors LP2,678,4306.18%$38.8 million0.20%+92,45213F
Driehaus Capital Management LLC2,661,1156.14%$38.5 million0.22%+916,12813F
BlackRock, Inc.2,660,0246.14%$38.5 million0.00%+526,26013F
Point72 Asset Management, L.P.2,366,4535.46%$34.2 million0.05%-356,30113F
Trails Edge Capital Partners, LP2,001,2824.62%$29.0 million4.60%+1,149,26913F
Frazier Life Sciences Management, L.P.1,809,8544.18%$26.2 million0.57%new13F
Vivo Capital, LLC1,612,9033.72%$23.3 million2.13%no change13F
Vanguard Capital Management LLC1,571,0223.63%$22.7 million0.00%+221,17213F
Caption Management, LLC1,118,0982.58%$16.2 million0.57%+1,031,39013F
Almitas Capital LLC1,026,8932.37%$14.9 million3.56%-503,44213F
Geode Capital Management, LLC958,4172.21%$13.9 million0.00%+265,89913F
Sofinnova Investments, Inc.865,1352.00%$12.5 million0.67%new13F
FMR LLC776,4621.79%$11.2 million0.00%-21,94913F
Morgan Stanley765,4251.77%$11.1 million0.00%+108,86013F
State Street Corp.736,2211.70%$10.7 million0.00%+76,64613F
Woodline Partners LP700,3541.62%$10.1 million0.03%-261,14713F
Dimensional Fund Advisors LP694,7431.60%$10.1 million0.00%+262,90313F
Goldman Sachs Group Inc.656,5841.52%$9.5 million0.00%+151,86613F
Jacobs Levy Equity Management, Inc.565,5971.31%$8.2 million0.03%+276,21213F
Acadian Asset Management LLC537,4791.24%$7.8 million0.01%-79,00213F
Siren, L.L.C.523,2121.21%$7.6 million0.15%new13F
Qube Research & Technologies Ltd437,0791.01%$6.3 million0.01%+402,89613F
Renaissance Technologies LLC387,9130.90%$5.6 million0.01%-20,28713F
Kennedy Capital Management LLC384,0360.89%$5.6 million0.10%+112,48213F
Northern Trust Corp.353,1970.82%$5.1 million0.00%+52,91813F
Algert Global LLC296,0850.68%$4.3 million0.05%+91,34613F
Acuta Capital Partners, LLC282,5640.65%$4.1 million2.85%+136,66413F
Charles Schwab Investment Management Inc.271,2640.63%$3.9 million0.00%+29,77913F
Vanguard Portfolio Management LLC251,4420.58%$3.6 million0.00%+112,87713F
Vanguard Fiduciary Trust Co.230,2020.53%$3.3 million0.00%+34,54413F
Prudential Financial Inc.224,1700.52%$3.2 million0.00%+178,36013F
D. E. Shaw & Co., Inc.195,6450.45%$2.8 million0.00%-274,62513F
Eversept Partners, LP190,0000.44%$2.7 million0.15%new13F
KVP Capital Advisors, LP185,0000.43%$2.7 million1.97%new13F
J. Goldman & Co LP176,7700.41%$2.6 million0.09%new13F
Millennium Management LLC147,7140.34%$2.1 million0.00%+38,78613F
Raymond James Financial Inc.138,5210.32%$2.0 million0.00%+30,07213F
Balyasny Asset Management L.P.111,1030.26%$1.6 million0.00%new13F
Elmind Capital, LP107,9000.25%$1.6 million0.39%-100,00013F
Nuveen, LLC104,7340.24%$1.5 million0.00%-22,08113F
Dafna Capital Management LLC102,6000.24%$1.5 million0.28%new13F
Bank of New York Mellon Corp92,0690.21%$1.3 million0.00%+12,42413F
China Universal Asset Management Co., Ltd.89,9400.21%$1.3 million0.08%+54,83113F
Citadel Advisors LLC81,9710.19%$1.2 million0.00%-149,54213F
SummitTX Capital, L.P.80,6630.19%$1.2 million0.03%new13F
American Century Companies Inc.76,8250.18%$1.1 million0.00%+11,18713F
Palumbo Wealth Management LLC71,7440.17%$1.0 million0.22%+33613F
AQR Capital Management LLC71,1140.16%$1.0 million0.00%+45,15713F
The 50 largest of the 136 funds that reported a position in DSGN in their 13F for the quarter ended 30 June 2026, by the value each reported.
Read moreShare of all is the fund's part of all the shares the funds reported. Change is shares against the fund's 13F for the quarter before. A 13F lists a manager's long positions in US-listed shares at the quarter's end. What is a 13F?

Options the funds reported on DSGN

FundOptionShares under the optionsValue of those sharesQuarter endedFiling
Citadel AdvisorsCalls13,900$201,13330 June 202613F
A 13F lists calls and puts by the shares they cover and what those shares were worth at the quarter's end, not what the options cost.
Read moreThey are not counted in the holdings above. A put gains when the stock falls, a call when it rises, and a fund may hold either to hedge.

Schedule 13D and 13G filed on the name, last twelve months

FiledScheduleWhoHoldingOf the classEvent dateRule or purposeFiling
14 August 202613G/APoint72 Asset Management, L.P. and 5 others2.4 million3.8%30 June 2026passive, under 20% (13d-1(c))EDGAR
14 August 202613GSirenia Capital Management LP and 3 others6.0 million9.5%30 June 2026passive, institutional (13d-1(b))EDGAR
9 June 202613GPoint72 Asset Management, L.P. and 5 others3.2 million5.1%8 June 2026passive, under 20% (13d-1(c))EDGAR
15 May 202613G/APoint72 Asset Management, L.P. and 5 others2.7 million4.4%31 March 2026passive, under 20% (13d-1(c))EDGAR
11 March 202613D/ASR One Capital Fund I Aggregator, LP and 3 others6.6 million10.7%9 March 2026Not applicable.EDGAR
17 February 202613G/APoint72 Asset Management, L.P. and 5 others5.4 million9.4%31 December 2025passive, under 20% (13d-1(c))EDGAR
18 November 202513D/ALogos Global Management LP and 4 others2.5 million4.4%14 November 2025The reporting persons filed this Schedule 13D because Dr. William was on the Issuer' board of directors. Dr. William resigned from the Issuer's board of directors on September 9, 2025. The reporting persons will routinely monitor the IssuerEDGAR
12 November 202513D/ALogos Global Management LP and 4 others3.3 million5.7%7 November 2025The reporting persons filed this Schedule 13D because Dr. William was on the Issuer's board of directors. Dr. William has resigned from the Issuer's board of directors on September 9, 2025. The reporting persons will routinely monitor the IEDGAR
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read moreAmendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short. 13D and 13G

Fails to deliver

Settlement dateShares failedPriceFile
30 September 2026884$12.62SEC
24 September 2026305$12.36SEC
22 September 2026317$12.55SEC
4 September 20269$15.03SEC
2 September 2026335$15.14SEC
1 September 2026638$15.09SEC
26 August 20266,929$15.68SEC
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.
Read moreLargest in the window: 6,929 on 26 August 2026. A fail is an operational fact about settlement, not a position.